C4X Discovery Holdings PLC (AIM:C4XD) shares rallied 13% to an intraday high of 19p on Thursday after the pharmaceuticals discovery company flagged the early potential of a new blood-borne cancer drug candidate.
The C4X MALT-1 inhibitor program has now advanced into the preclinical candidate selection phase.
Shares drew back from higher to 17.08p in the early afternoon trading session, giving a market value of £43mln.